文献速递神经肿瘤脊柱脊髓外科

特发性与2型神经纤维瘤病相关脊髓脑膜瘤的临床表现与临床结局:一项回顾性单机构经验

Presenting characteristics and clinical outcomes of idiopathic versus neurofibromatosis type 2-associated spinal meningiomas: a retrospective institutional experience.
PubMed 文献 · J Neurosurg Spine · 2024-11-15

该多机构回顾性队列研究纳入1998至2020年间接受手术的166例脊髓脑膜瘤患者,其中15例(9%)合并2型神经纤维瘤病(NF2)。NF2患者确诊年龄更早(平均33.3岁),进展率更高(40%)且进展时间更短(平均2.8年)。特发性脊髓脑膜瘤仍为相对良性且高度可控的疾病。

要点

  • 166例手术治疗的脊髓脑膜瘤中,15例(9%)合并NF2诊断。
  • NF2患者平均确诊年龄33.3岁,显著早于其他患者。
  • NF2患者进展率40%,显著高于其他患者,平均进展时间2.8年。

核心结论

  • 在166例手术治疗的脊髓脑膜瘤患者中,NF2患者就诊更早、进展更早且进展更频繁。
  • 肿瘤影像学特征在各组间相对一致。
  • 特发性脊髓脑膜瘤仍为相对良性且高度可控的疾病,但考虑肿瘤分子特征和更广泛的临床病史对提供有效且个体化的患者护理至关重要。

研究设计与样本

  • 多机构回顾性队列研究,回顾性审查医疗记录以收集患者人口学、临床表现、肿瘤特征、治疗和结局数据。
  • 纳入1998年至2020年间接受手术的166例脊髓脑膜瘤患者。

主要发现

  • 共纳入166例患者,其中女性133例(80%);15例(9%)合并NF2诊断。
  • 手术时平均年龄58岁(标准差18),平均术前卡氏功能状态评分76分(标准差11)。
  • 最常见表现症状为感觉改变(60%)和乏力(59%);大多数肿瘤位于胸椎(72%)。
  • 全切除(GTR)在154例(93%)中实现;8例次全切除患者接受放疗,无人接受化疗。
  • 18例(11%)术后出现影像学复发,平均复发时间4.2年;NF2患者平均确诊年龄33.3岁(标准差15.4),显著早于其他患者,进展率40%显著更高,平均进展时间2.8年(标准差3.7)。

关键数值与推荐

  • 肿瘤体积、T2脊髓水肿、硬膜尾征和钙化等影像学特征在NF2与非NF2患者间、全切除与次全切除患者间、以及复发与未复发患者间均相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spinal meningioma (SM) is a pathology with an estimated incidence of nearly 1000 diagnoses per year in the United States and presents in 20% of patients with neurofibromatosis type 2 (NF2). This multi-institutional retrospective cohort study aimed to assess clinical outcomes for patients with SM who underwent surgery between 1998 and 2020 with stratification by NF2 mutation status. METHODS: Medical records were reviewed retrospectively to collect data on patient demographics, clinical presentation, tumor characteristics, treatment, and outcomes. Analyses were done to determine radiographic predictors of gross-total resection (GTR) and tumor recurrence, to assess radiographic characteristics of NF2-associated tumors, and to determine progression-free survival between groups. RESULTS: A total of 166 patients who received surgery for SM during the study period were included, of whom 133 were women (80%). Fifteen (9%) patients had a concurrent NF2 diagnosis. The mean age at surgery was 58 (SD 18) years. The mean presenting Karnofsky Performance Status score was 76 (SD 11), and the most common presenting symptoms were sensation changes (60%) and weakness (59%). Most tumors were in the thoracic spine (72%). GTR was achieved in 154 cases (93%). Eight patients with subtotal resection were treated with radiation therapy, and none received chemotherapy. Eighteen patients (11%) experienced radiographic recurrence of disease following surgery, with a mean time to recurrence of 4.2 years. NF2 patients were diagnosed at a significantly earlier mean age (33.3 [SD 15.4] years) compared with other patients. NF2 patients experienced progression at a significantly higher rate than other patients (40%), and in less time (mean 2.8 [SD 3.7] years). Radiographic characteristics, including tumor volume, T2 cord edema, dural tail sign, and calcification, were similar between NF2 and non-NF2 patients, between patients who underwent gross-total versus subtotal resection, and between patients who experienced tumor recurrence and those who did not. CONCLUSIONS: In this study of 166 surgically treated patients with SM, patients with NF2 presented earlier, experienced earlier progression, and experienced progression more frequently compared with those without NF2. Radiographic characteristics of tumors were relatively consistent between groups. While idiopathic SMs remain a relatively benign and highly manageable disease, considering tumor molecular characteristics and broader clinical history is paramount in providing efficacious and individualized patient care.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Nawabi NLA, Chalif JI, Renauld S, et al. Presenting characteristics and clinical outcomes of idiopathic versus neurofibromatosis type 2-associated spinal meningiomas: a retrospective institutional experience. J Neurosurg Spine. 2024. PMID: 39546794. doi:10.3171/2024.7.SPINE24607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。